BACKGROUND INFORMATION ON THE PROCEDURE 
1. 
Submission of the dossier 
The  applicant  Nycomed  Austria  GmbH  submitted  on    4  July  2002  an  application  for  Marketing 
Authorisation  to  the  European  Agency  for  the  Evaluation  of  Medicinal  Products  (EMEA)  for 
TachoSil, in accordance with the centralised procedure falling within the scope of Part B of the Annex 
to Council Regulation No (EEC) 2309/93 of 22 July 1993, as amended. 
The Rapporteur and Co-Rapporteur appointed by the CPMP were: 
Rapporteur:  Dr. Manfred Haase 
Co-Rapporteur: 
Dr. Ian Hudson  
2. 
Steps taken for the assessment of the product 
• 
• 
• 
• 
• 
• 
• 
• 
The procedure started on 22 July 2002. 
The  Rapporteur's  first  Assessment  Report  was  circulated  to  all  CPMP  members  on  
30 September 2002 . The Co-Rapporteur's first Assessment Report was circulated to all CPMP 
members on 10 September 2002. 
During  the  meeting  on  19  November  2002,  the  CPMP  agreed  on  the  consolidated  List  of 
Questions to be sent to the applicant. The final consolidated List of Questions was sent to the 
applicant on  21 November 2002. 
The  applicant  submitted  the  responses  to  the  CPMP  consolidated  List  of  Questions  on  14 
October 2003. 
The Rapporteurs circulated the Joint Assessment Report on the applicant’s responses to the List 
of Questions to all CPMP members on  24 November 2003. 
During  the  CPMP  meeting  on  18  December  2003,  the  CPMP  agreed  on  a  list  of  outstanding 
issues to be addressed in writing by the applicant. 
The Rapporteurs circulated the Joint Assessment Report on the applicant’s responses to the List 
of outstanding issues to all CPMP members on 3 February 2004. 
During  the  meeting  on    24-26  February  2004,  the  CPMP,  in  the  light  of  the  overall  data 
submitted  and  the  scientific  discussion  within  the  Committee,  issued  a  positive  opinion  for 
granting  a  Marketing  Authorisation  to  TachoSil  on  26  February  2004.  The  applicant  provided 
the  letter  of  undertaking  on  the  follow-up  measures  to  be  fulfilled  post-authorisation  on  26 
February 2004. 
1/1 
               EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
